These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 13987288)
21. Some information concerning the treatment by Ypenyl. Dostálová O; Subrtová Z; Holík F Neoplasma; 1970; 17(3):311-5. PubMed ID: 5430501 [No Abstract] [Full Text] [Related]
23. [EXPERIMENTAL AND CLINICAL FINDINGS ON THE THERAPEUTIC USE OF A NEW ALKYLATING DRUG: URACIL MUSTARD]. BALLERINI G; CASTOLDI G; RICCI N; TENZE L Clin Ter; 1965 Jan; 32():49-61. PubMed ID: 14262587 [No Abstract] [Full Text] [Related]
24. [Pharmacological comparisons on a new antitumor agent: dopan]. MAZZUCCHELLI L Boll Chim Farm; 1962 Aug; 101():630-2. PubMed ID: 13934278 [No Abstract] [Full Text] [Related]
25. COMPARISON OF CYCLOPHOSPHAMIDE (CYTOXAN AND URACIL MUSTARD (U-8344) IN CHRONIC GRANULOCYTIC LEUKEMIA. FROMMEYER WB Cancer; 1964 Mar; 17():288-96. PubMed ID: 14132176 [No Abstract] [Full Text] [Related]
27. [A CASE OF ACUTE POISONING WITH DOPAN]. BOGORODSKAIA TA; MIKHAILOVA EN; OGIBINA LN; SHCHERBA MM Ter Arkh; 1965 Jan; 37():107-9. PubMed ID: 14342983 [No Abstract] [Full Text] [Related]
28. [REDUCING THE TOXICITY OF DOPAN BY MEANS OF AMINOETHYL-ISOTHIURONIUM (AET) IN EXPERIMENTS ON MONKEYS]. SPASSKAIA IG; PLATONOVA GN; SOLOPAEVA IM; SEMENOV LF; ZEITUNIAN KA; LARIONOV LF Vopr Onkol; 1963; 9():44-6. PubMed ID: 14148614 [No Abstract] [Full Text] [Related]
29. [On dopan therapy of patients with lymphogranulomatosis, chronic lymphatic leukemia and other systemic blood diseases]. PETROV KIa Sov Med; 1961 Nov; 25():13-7. PubMed ID: 14485925 [No Abstract] [Full Text] [Related]
30. Effect of uracil mustard in malignant lymphoma and chronic lymphatic leukemia. THEOLOGIDES A; KENNEDY BJ Minn Med; 1962 Feb; 45():165-8. PubMed ID: 13920550 [No Abstract] [Full Text] [Related]
31. [EXPERIMENTAL CHROMOSOME ALTERATIONS DUE TO CYCLOPHOSPHAMIDE AND URACIL-MUSTARD]. BALLERINI G; BOSI L; PARESCHI PL; PUNTURIERI E Arcisp S Anna Ferrara; 1964; 17():1139-52. PubMed ID: 14265725 [No Abstract] [Full Text] [Related]
32. 2-Fluoroethylamines. 3. Some alkylating agents derived from uracil. Martinez AP; Lee WW; Goodman L J Med Chem; 1968 Mar; 11(2):384-7. PubMed ID: 5663637 [No Abstract] [Full Text] [Related]
33. Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard). SAMPEY JR J S C Med Assoc; 1962 May; 58():175-6. PubMed ID: 14496660 [No Abstract] [Full Text] [Related]
34. EFFECTS OF URACIL MUSTARD ON INCORPORATION OF L-LYSINE-U-14C INTO ACIDIC NUCLEOLAR PROTEINS OF THE WALKER TUMOR AND LIVER. DESJARDINS R; BUSCH H Tex Rep Biol Med; 1964; 22():444-53. PubMed ID: 14221508 [No Abstract] [Full Text] [Related]
35. NECROTIZING TOXOPLASMIC ENCEPHALITIS AND HERPETIC PNEUMONIA COMPLICATING TREATED HODGKIN'S DISEASE. REPORT OF A CASE. CHEEVER AW; VALSAMIS MP; RABSON AS N Engl J Med; 1965 Jan; 272():26-9. PubMed ID: 14219210 [No Abstract] [Full Text] [Related]
36. [TREATMENT OF LYMPHOGRANULOMATOSIS WITH DOPAN AND DEGRANOL]. KOLESNIKOV IuP Sov Med; 1965 Jan; 28():116-9. PubMed ID: 14307884 [No Abstract] [Full Text] [Related]
37. An application of 3D-QSAR to the analysis of the sequence specificity of DNA alkylation by uracil mustard. Doweyko AM; Mattes WB Biochemistry; 1992 Oct; 31(39):9388-92. PubMed ID: 1327114 [TBL] [Abstract][Full Text] [Related]